Company Announces Successful Scan Using Novel 3T MRI Scanner
By MedImaging International staff writers Posted on 06 Jun 2016 |
Image: The model of the first 3T MRI scanner with high-temperature coils (Photo courtesy of Mitsubishi Electric).
A leading manufacturer of electrical and electronic products, and systems, and two Japanese universities have successfully imaged a mouse fetus using a small model of a new 3T Magnetic Resonance Imaging (MRI) scanner that uses high-temperature superconducting coils.
Most MRI scanners in use today have magnets that are cooled by liquid helium, a gas that is becoming increasingly scarce. The new technology uses high-temperature superconducting coils that do not require cooling. The company expects to develop a half-size MRI scanner by 2020, and to be able to commercialize a full-size scanner within five years, in 2021.
Mitsubishi Electric (Tokyo, Japan), Kyoto University and Tohoku University, successfully developed the 3T magnetic field by increasing the precision of the coil winding. The company used laser displacement meters to measure the coil height and then adjusted it with correction sheets. The researchers succeeded in developing a pancake coil with a winding accuracy of 0.1 mm and an outer diameter of approximately 400 mm, and were able to achieve sufficient magnetic field homogeneity for use in commercial imaging. The model scanner has an imaging space with a diameter of 25 mm – the same level as that in a 230-mm diameter and 650-mm cylinder commercial-sized MRI scanner. Mitsubishi Electric used the 3T scanner model to successfully image a 25-millimeter mouse fetus.
Related Links:
Mitsubishi Electric
Most MRI scanners in use today have magnets that are cooled by liquid helium, a gas that is becoming increasingly scarce. The new technology uses high-temperature superconducting coils that do not require cooling. The company expects to develop a half-size MRI scanner by 2020, and to be able to commercialize a full-size scanner within five years, in 2021.
Mitsubishi Electric (Tokyo, Japan), Kyoto University and Tohoku University, successfully developed the 3T magnetic field by increasing the precision of the coil winding. The company used laser displacement meters to measure the coil height and then adjusted it with correction sheets. The researchers succeeded in developing a pancake coil with a winding accuracy of 0.1 mm and an outer diameter of approximately 400 mm, and were able to achieve sufficient magnetic field homogeneity for use in commercial imaging. The model scanner has an imaging space with a diameter of 25 mm – the same level as that in a 230-mm diameter and 650-mm cylinder commercial-sized MRI scanner. Mitsubishi Electric used the 3T scanner model to successfully image a 25-millimeter mouse fetus.
Related Links:
Mitsubishi Electric
Latest MRI News
- Low-Cost Whole-Body MRI Device Combined with AI Generates High-Quality Results
- World's First Whole-Body Ultra-High Field MRI Officially Comes To Market
- World's First Sensor Detects Errors in MRI Scans Using Laser Light and Gas
- Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans
- Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients
- PET/MRI Improves Diagnostic Accuracy for Prostate Cancer Patients
- Next Generation MR-Guided Focused Ultrasound Ushers In Future of Incisionless Neurosurgery
- Two-Part MRI Scan Detects Prostate Cancer More Quickly without Compromising Diagnostic Quality
- World’s Most Powerful MRI Machine Images Living Brain with Unrivaled Clarity
- New Whole-Body Imaging Technology Makes It Possible to View Inflammation on MRI Scan
- Combining Prostate MRI with Blood Test Can Avoid Unnecessary Prostate Biopsies
- New Treatment Combines MRI and Ultrasound to Control Prostate Cancer without Serious Side Effects
- MRI Improves Diagnosis and Treatment of Prostate Cancer
- Combined PET-MRI Scan Improves Treatment for Early Breast Cancer Patients
- 4D MRI Could Improve Clinical Assessment of Heart Blood Flow Abnormalities
- MRI-Guided Focused Ultrasound Therapy Shows Promise in Treating Prostate Cancer